Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. CAS jointly implements the ASAP initiative alongside the Michael J. Fox Foundation for Parkinson’s Research (MJFF). Dr. Ekemini A.U. Riley has led the global coordinated research effort from its inception and continues to act as the initiative’s managing director.

In early 2020, scientists at Stanford University, the University of Michigan, and Emory University developed a model method to detect COVID-19 virus RNA in sewage and provide actionable information on the level of infection in a community. SCAN is partnering with communities in California and the life sciences research company Verily, and is offering communities across the U.S. an opportunity to monitor their own wastewater for COVID-19 and other respiratory viruses using SCAN’s method.

Launched in September 2022 and taking learnings from the development of Aligning Science Across Parkinson's, a core mission of Breakthrough Discoveries for Thriving With Bipolar Disorder (BD²) is to provide unparalleled access to breakthrough insights on bipolar disorder through four unique programs. The BD² Discovery Grants, Brain Omics, Genetics Platforms, and the Integrated Network are designed to share data, methods, and resources across initiatives and the bipolar disorder research community. This initiative is powered by a funder collaborative and CAS manages the involvement of a founding funder.

Aligning Research to Impact Autism (ARIA) is a new initiative that connects emerging research, insights, and promising technologies from across scientific fields. ARIA aims to advance scientific discovery and create more therapeutic opportunities for people with profound autism and people on the spectrum who seek additional support.